Antimicrobial resistance determinant microarray for analysis of multi-drug resistant isolates

The prevalence of multidrug-resistant infections in personnel wounded in Iraq and Afghanistan has made it challenging for physicians to choose effective therapeutics in a timely fashion. To address the challenge of identifying the potential for drug resistance, we have developed the Antimicrobial Resistance Determinant Microarray (ARDM) to provide DNAbased analysis for over 250 resistance genes covering 12 classes of antibiotics. Over 70 drug-resistant bacteria from different geographic regions have been analyzed on ARDM, with significant differences in patterns of resistance identified: genes for resistance to sulfonamides, trimethoprim, chloramphenicol, rifampin, and macrolide-lincosamidesulfonamide drugs were more frequently identified in isolates from sources in Iraq/Afghanistan. Of particular concern was the presence of genes responsible for resistance to many of the last-resort antibiotics used to treat war traumaassociated infections.

[1]  R. Dhillon,et al.  ESBLs: A Clear and Present Danger? , 2011, Critical care research and practice.

[2]  C. Taitt,et al.  Microarray for rapid detection of microbial resistance genotypes , 2011 .

[3]  G. Wortmann,et al.  Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq. , 2011, The Journal of trauma.

[4]  Enhancement of deoxyribonucleic acid microarray performance using post-hybridization signal amplification. , 2010, Analytica chimica acta.

[5]  M. Falagas,et al.  Extended-spectrum b-lactamase-producing organisms , 2022 .

[6]  D. Hospenthal,et al.  Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. , 2009, Military medicine.

[7]  G. Wortmann,et al.  Emergence of Multidrug Resistance in Bacteria and Impact on Antibiotic Expenditure at a Major Army Medical Center Caring for Soldiers Wounded in Iraq and Afghanistan , 2008, Infection Control & Hospital Epidemiology.

[8]  D. Mozingo.  Trauma-related Infections in Battlefield Casualties From Iraq , 2008 .

[9]  J. Patel,et al.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Ecker,et al.  Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center , 2006, Antimicrobial Agents and Chemotherapy.

[11]  Robert A. Bonomo,et al.  Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .

[12]  R. Frenck,et al.  Posttreatment Changes in Escherichia coli Antimicrobial Susceptibility Rates among Diarrheic Patients Treated with Ciprofloxacin , 2005, Antimicrobial Agents and Chemotherapy.

[13]  D. Fry,et al.  Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. , 2005, Archives of surgery.

[14]  J. Bartlett.  Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project , 2004 .

[15]  E. Hultén,et al.  Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. , 2004, MMWR. Morbidity and mortality weekly report.

[16]  F. Butler,et al.  Antibiotics in tactical combat casualty care 2002. , 2003, Military medicine.